Study Warns UK-US Pharma Deal Could Cost 229,000 Lives

A new analysis has warned that the UK-US pharmaceutical trade agreement could contribute to nearly 229,000 avoidable deaths in England by increasing medicine spending at the expense of other National Health Service (NHS) services, reported by CNN.

The report said the agreement could cost the NHS an additional £45 billion by 2036.

Researchers argued that unless the government provides extra funding, diverting resources from other healthcare services could worsen health inequalities and increase deaths, particularly among patients with heart disease, respiratory illnesses, gastrointestinal conditions and cancer.

The UK government has defended the agreement, saying it will protect medicine supplies and encourage investment in healthcare and industry.

Related Tweet:

Analysis published in the British Medical Journal has warned there could be 200,000 avoidable deaths in England to complete the terms of the UK-US trade deal.

This is because the NHS will have to divert £45 billion from essential services to pay for new medicines under the terms… pic.twitter.com/zfGobOZyI5

— Sky News (@SkyNews) July 2, 2026

Also Read:

CDC Warns of Early Surge In West Nile Virus Cases

As of June 30, health officials had confirmed at least 48 cases across 23 states, including 38 severe infections—well above the historical average of about 10 cases typically reported by the end of June.

tippinsightsTIPP Staff